Results from the PREVENT-SCD (PRospective EValuation of VENtricular Tachyarrhythmic Events and Sudden Cardiac Death in Patients with Left Ventricular Dysfunction)trial, published in the journal Clinical Research Cardiology, reinforce the use of Cambridge Heart's (Tewksbury, Massachusetts) test to identify patients at risk of Sudden Cardiac Death (SCD). (Medical Device Daily) Read More
